MARKET

AXGN

AXGN

Axogen Inc.
NASDAQ

Real-time Quotes | Nasdaq Last Sale

19.03
-0.24
-1.25%
Opening 10:59 04/23 EDT
OPEN
19.26
PREV CLOSE
19.27
HIGH
19.45
LOW
19.03
VOLUME
8.87K
TURNOVER
--
52 WEEK HIGH
22.89
52 WEEK LOW
7.65
MARKET CAP
775.88M
P/E (TTM)
-31.9242
1D
5D
1M
3M
1Y
5Y
Peripheral Nerve Repair Devices Market Size, Growth | Report [2025]
Japan, Japan, Thu, 22 Apr 2021 01:07:23 / Comserve Inc. / -- Peripheral Nerve Repair Devices Market Opportunities, Size, Share, Emerging Trends,...
Comserve · 1d ago
Insider Trends: Insider at AxoGen Converts Options in Mist of 90-Day Buying Trend
MT Newswires · 2d ago
If You Had Bought AxoGen (NASDAQ:AXGN) Stock Five Years Ago, You Could Pocket A 224% Gain Today
Simply Wall St. · 3d ago
Nerve Repair Biomaterials Market Research Report by Device, by Service, by Industry – Global Forecast to 2025 – Cumulative Impact of COVID-19
Heraldkeepers · 04/15 09:05
Axogen, Inc. to Report First Quarter Financial Results and Host Conference Call on May 5, 2021
ALACHUA Fla. and TAMPA, Fla., April 14, 2021 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral nerves, today announced that it will report firs...
GlobeNewswire · 04/14 11:07
Nerve Repair and Regeneration Market Demand, Trends and Business Opportunities with Leading Players – AxoGen Inc., Baxter International Inc., Boston Scientific Corporation and More
Market Insight Reports · 04/14 06:48
Nerve Biologic Products Market Entry Strategies, Counter measures of Economic Impact Channels to 2027
Apr 10, 2021 (Market Insight Reports) -- Global Nerve Biologic Products Market Nerve biologic products include artificial nerve conduit, nerve graft, nerve...
Market Insight Reports · 04/10 10:50
Nerve Repair and Regeneration Market Growth, Drivers, Demand, Merger, Acquisition, SWOT Analysis, PESTELE Analysis and Business Opportunities by 2027
Market Insight Reports · 04/06 13:57
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of AXGN. Analyze the recent business situations of Axogen Inc. through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 7 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average AXGN stock price target is 23.50 with a high estimate of 27.00 and a low estimate of 16.00.
EPS
Institutional Holdings
Institutions: 208
Institutional Holdings: 44.10M
% Owned: 108.17%
Shares Outstanding: 40.77M
TypeInstitutionsShares
Increased
38
1.76M
New
17
1.01M
Decreased
38
2.01M
Sold Out
19
614.58K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+0.85%
Healthcare Equipment & Supplies
+0.64%
Key Executives
Chairman/President/Chief Executive Officer/Director
Karen Zaderej
Chief Financial Officer
Peter Mariani
Chief Human Resource Officer
Maria Martinez
Chief Compliance Officer/General Counsel
Brad Ottinger
Vice President - Operations
Mike Donovan
Vice President
Erick DeVinney
Vice President
Mark Friedman
Other
Isabelle Billet
Other
Eric Sandberg
Other
Angelo Scopelianos
Lead Director/Independent Director
Amy Wendell
Independent Director
Quentin Blackford
Independent Director
Gregory Freitag
Independent Director
Mark Gold
Independent Director
Alan Levine
Independent Director
Mark Stephen Gold
Independent Director
Guido Neels
Independent Director
Paul Thomas
Declaration Date
Dividend Per Share
Ex-Div Date
12/21/2009
Dividend USD 1
01/27/2010
--
Dividend USD 0.06
02/23/2005
About AXGN
AxoGen, Inc. offers surgical solutions for peripheral nerve injuries. The Company provides products and education to improve surgical treatment algorithms for peripheral nerve injuries. Its portfolio of products includes Avance Nerve Graft, AxoGuard Nerve Connector, AxoGuard Nerve Protector and Avive Soft Tissue Membrane. Along with these core surgical products, the Company also offers the AxoTouch Two-Point Discriminator, and AcroVal Neurosensory and Motor Testing System. These evaluation and measurement tools assist healthcare professionals in detecting changes in sensation; assessing return of sensory, grip and pinch function; evaluating treatment interventions, and providing feedback to patients on nerve function. Its portfolio of products is available in the United States, Canada, the United Kingdom and several European and other countries. The Company's products are used by surgeons during surgical interventions to repair a range of nerve injuries throughout the body.

Webull offers kinds of AxoGen Inc stock information, including NASDAQ:AXGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AXGN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AXGN stock methods without spending real money on the virtual paper trading platform.